Invest in the Platform the World Has Been Waiting For
SEDU is raising its seed round to fund the private beta launch in India and begin the Southeast Asia expansion. We are seeking investors who understand the intersection of health-tech, privacy technology, and emerging market growth.
Market Opportunity
The global sexual wellness market is projected to reach $120 billion by 2030, driven by rising digital health adoption, destigmatisation trends, and an increasingly connected emerging market population.
SEDU targets the underserved privacy-sensitive segment — users who will not engage with existing platforms due to identity exposure risk, cultural taboos, or lack of localised content.
This segment has no dominant player. The whitespace is enormous.
Why Now
Three converging trends make 2026 the right moment to build SEDU:
- →Smartphone penetration in South Asia and SEA has crossed 70%, creating the digital infrastructure for a mobile-first platform.
- →Post-pandemic health literacy has risen dramatically, with users increasingly comfortable seeking health information digitally.
- →Regulatory focus on data privacy (DPDPA India, PDPA ASEAN) creates a first-mover advantage for privacy-native platforms.
Revenue Model
B2C Subscription
PrimaryFreemium access to core educational content. Premium subscription unlocks advanced personalised pathways, specialist Q&A access, and offline learning.
Clinical Ecosystem Commission
High MarginSEDU takes a platform commission on specialist consultations booked within the app. Specialists pay to be listed; users pay for sessions.
B2B Wellness Partnerships
ExpansionEnterprise health and wellness programmes licensing SEDU content modules for employee education. Corporate mental health budgets are rapidly growing.
Investment Highlights
- Privacy-first architecture creating a defensible moat in an otherwise commoditised space.
- Deep cultural localisation strategy targeting markets with 3.5B+ underserved individuals.
- Dual revenue model: B2C subscription + B2B2C clinical ecosystem commissions.
- Pre-seed validation: early waitlist traction, partner interest, and investor outreach from 15+ countries.
- Founder-led, mission-driven team with domain expertise in health-tech and product development.
- TAM expansion built into the product roadmap — not requiring separate investment theses.
Request Investor Briefing
Complete this form to receive our pitch deck, TAM analysis, and financial projections. For other questions, contact us here.